People with eating disorders are taking GLP-1s and doctors are alarmed
The Washington Post
Overall Assessment
The article effectively highlights emerging concerns about GLP-1 use among individuals with eating disorders through compelling patient narratives and expert input. It maintains a largely objective tone while emphasizing risks, though the headline amplifies alarm more than the body justifies. Sourcing is diverse and credible, but systemic context and counter-narratives are underdeveloped.
"When her 4-year-old daughter, who is tall for her age, burst into tears after not being able to find a birthday dress that fit"
Sympathy Appeal
Headline & Lead 75/100
The headline emphasizes alarm among doctors, which aligns loosely with the article’s content but amplifies emotional impact over measured reporting. The lead, however, grounds the story in a personal narrative, offering a humanizing entry point.
✕ Sensationalism: The headline uses emotionally charged language ('doctors are alarmed') to heighten concern, which may overstate the urgency relative to the article's more measured tone.
"People with eating disorders are taking GLP-1s and doctors are alarmed"
✕ Headline / Body Mismatch: While the body presents a nuanced discussion of risk and usage, the headline frames the issue as a crisis, potentially exaggerating the prevalence of misuse.
"People with eating disorders are taking GLP-1s and doctors are alarmed"
Language & Tone 82/100
The tone is generally restrained and empathetic, though occasional word choices lean toward emotional resonance. It avoids overt editorializing while allowing patient voices to convey moral weight.
✕ Loaded Language: Use of emotionally resonant phrases like 'fueled a national weight-loss craze' introduces a subtle negative valence around public behavior.
"fueling a national weight-loss craze"
✕ Passive-Voice Agency Obfuscation: Phrasing like 'are being abused' avoids specifying who is responsible, reducing clarity about accountability.
"Novo Nordisk did not respond directly to whether it believes its drugs are being abused"
✕ Sympathy Appeal: The article evokes empathy through patient stories, particularly minors and those in crisis, which supports engagement but risks emotional overreach.
"When her 4-year-old daughter, who is tall for her age, burst into tears after not being able to find a birthday dress that fit"
✕ Euphemism: Use of 'not feel well enough to get up and move around' in quotes reflects patient deception but is presented without critical commentary on medical screening failures.
"indicated she did not 'feel well enough to get up and move around'"
Balance 88/100
Strong sourcing with diverse, credible voices. The article fairly represents medical, patient, and corporate perspectives, though it could more directly challenge industry deflections.
✓ Comprehensive Sourcing: The article includes multiple doctors, patients, researchers, and institutional voices, offering a well-rounded perspective.
✓ Viewpoint Diversity: Sources include clinicians, eating disorder specialists, patients, pharmaceutical companies, and regulatory bodies, representing a broad spectrum of stakeholders.
✓ Proper Attribution: Claims are consistently attributed to individuals or studies, avoiding vague assertions.
"Rebecka Peebles, who handles clinical intake for a national eating disorder treatment provider, Monte Nido, said..."
✕ Uncritical Authority Quotation: Novo Nordisk’s statement is presented without pushback on its deflection of responsibility to doctors, though the context implies critique.
"We recognize that eating disorders are serious conditions... we trust that health care professionals... are appropriately evaluating the patient’s medical history"
Story Angle 78/100
The story centers on individual risk and moral tension around drug access, prioritizing personal consequences over structural analysis, though it raises systemic concerns implicitly.
✕ Narrative Framing: The story is framed around individual patient journeys, which personalizes the issue but risks episodic over systemic focus.
✕ Framing by Emphasis: Emphasis is placed on risks and relapses, with less attention to potential benefits for non-disordered users, creating a cautionary arc.
✕ Episodic Framing: Each patient case is presented as a standalone story, which illustrates impact but doesn’t fully connect to broader policy or cultural trends.
✕ Moral Framing: The narrative subtly positions GLP-1 misuse as a moral hazard, especially with youth access and deception, implying ethical failure.
"They went online and lied about their age and weight to gain access, sometimes using their parents’ credit cards"
Completeness 85/100
Provides substantial context on medical, psychological, and social dimensions, though it could better balance risk portrayal with broader usage patterns.
✓ Contextualisation: The article provides background on eating disorder treatment, drug mechanisms, and advertising influence, enriching understanding.
"Part of treatment for patients with eating disorders is helping them recognize their natural hunger cues. GLP-1s suppress those cues, providers said"
✕ Decontextualised Statistics: The 1% figure from NEJM is presented without discussion of confidence intervals or study limitations, slightly oversimplifying risk.
"estimated that more than 420,000 people could develop an eating disorder with long-term use of the drugs"
✕ Omission: No mention of how many patients safely use GLP-1s without disordered behavior, potentially skewing perceived risk.
✕ Cherry-Picking: Focuses on extreme cases (e.g., 13-day fasts), which are illustrative but may not represent typical misuse patterns.
"did not eat for 13 days, losing 21 pounds in less than two weeks"
Medical Safety is framed as endangered due to unregulated access and insufficient screening
The article emphasizes patient deception in obtaining prescriptions, lack of screening, and serious health consequences like organ failure and malnutrition. Loaded language and narrative framing amplify risk.
"AJ Jasper, 40, has been struggling with anorexia for about 30 years. Three years ago, at a time when he was a healthy weight, he relapsed after purchasing GLP-1s from various apps without ever seeing a doctor. Using multiple drugs at once, he dropped 50 pounds within three to four months."
Public Health is framed as being in crisis due to widespread misuse and normalization of dangerous weight-loss behavior
Framing by emphasis and moral framing highlight youth access, deceptive practices, and advertising influence, suggesting a breakdown in public health safeguards.
"Even some younger teens are getting prescriptions, providers say, despite the fact that major telehealth websites selling the drugs require that patients be at least 18. They went online and lied about their age and weight to gain access, sometimes using their parents’ credit cards."
Media and advertising are framed as harmful by glamorizing thinness and normalizing dangerous weight-loss drugs
Loaded language and sympathy appeal highlight how advertising distorts social norms and pressures youth, contributing to disordered behavior.
"Rebecca Boswell, who directs the Princeton Center for Eating Disorders, said she was speaking with a group of eighth-graders about body image when they began singing the Ozempic advertising jingle, in unison. 'It was unnerving,' she said."
Telehealth platforms and apps are framed as adversarial by enabling easy, unmonitored access to dangerous medications
Passive voice agency obfuscation and narrative framing depict digital platforms as facilitators of harm without sufficient oversight or accountability.
"On an online site promising easy prescriptions, she typed that she was 150 pounds (she wasn’t) and indicated she did not 'feel well enough to get up and move around' (which also wasn’t true). Then she entered her credit card information."
Women are framed as socially pressured and marginalized by weight stigma, driving dangerous behaviors
Sympathy appeal and moral framing center female experiences of body shame and societal judgment, linking cultural exclusion to medical risk.
"The most she ever weighed was 240 and prefers how she looks now after suffering the daily indignities of having other people judge her weight."
The article effectively highlights emerging concerns about GLP-1 use among individuals with eating disorders through compelling patient narratives and expert input. It maintains a largely objective tone while emphasizing risks, though the headline amplifies alarm more than the body justifies. Sourcing is diverse and credible, but systemic context and counter-narratives are underdeveloped.
Medical professionals are observing increased use of GLP-1 weight-loss drugs among individuals with eating disorders, raising concerns about relapse and treatment interference. Patient stories and clinical observations suggest potential risks, though regulatory and pharmaceutical responses remain limited. The FDA has not updated labeling to reflect eating disorder risks.
The Washington Post — Lifestyle - Health
Based on the last 60 days of articles
The Washington Post
